211 related articles for article (PubMed ID: 2561589)
1. Human alveolar macrophages release a factor that inhibits phagocyte function.
Sibille Y; Merrill WW; Naegel GP; Care SB; Cooper JA; Reynolds HY
Am J Respir Cell Mol Biol; 1989 Nov; 1(5):407-16. PubMed ID: 2561589
[TBL] [Abstract][Full Text] [Related]
2. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
Kew RR; Grimaldi CM; Furie MB; Fleit HB
J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
[TBL] [Abstract][Full Text] [Related]
3. Deactivation of guinea pig pulmonary alveolar macrophage responses to N-formyl-methionyl-leucyl-phenylalanine: chemotaxis, superoxide generation, and binding.
Daughaday CC; Mehta J; Spilberg I; Atkinson JP
J Immunol; 1985 Mar; 134(3):1823-6. PubMed ID: 2981922
[TBL] [Abstract][Full Text] [Related]
4. Signal transduction in human alveolar macrophages: diminished chemotactic response to FMLP correlates with a diminished density of Gi proteins and FMLP receptors.
Beaty CD; Martin TR; Wilson CB
Am J Respir Cell Mol Biol; 1991 Jul; 5(1):87-92. PubMed ID: 1908689
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil chemotactic activity produced by normal and activated human bronchoalveolar lavage cells.
Sibille Y; Naegel GP; Merrill WW; Young KR; Care SB; Reynolds HY
J Lab Clin Med; 1987 Nov; 110(5):624-33. PubMed ID: 2822825
[TBL] [Abstract][Full Text] [Related]
6. Wheat germ agglutinin specifically inhibits formyl peptide-induced polymorphonuclear leukocyte chemotaxis.
Perez HD; Ong R; Khanna K; Banda D; Goldstein IM
J Immunol; 1982 Dec; 129(6):2718-24. PubMed ID: 6897258
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte inhibitory factor (LIF) potentiates human macrophage aggregation and activation responses to calcium ionophore A23187 and directly induces leukotriene B4 and thromboxane A2 release.
Conti P; Barbacane RC; Reale M; Panara MR; Placido FC; Mier JW; Castracane JM; Dempsey RA
Biotechnol Ther; 1993; 4(3-4):239-52. PubMed ID: 8292972
[TBL] [Abstract][Full Text] [Related]
8. Negative effect of a protein kinase C inhibitor (H-7) on human polymorphonuclear neutrophil locomotion.
Gaudry M; Perianin A; Marquetty C; Hakim J
Immunology; 1988 Apr; 63(4):715-9. PubMed ID: 2835313
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of a derivative of wheat germ agglutinin which specifically inhibits polymorphonuclear leukocyte chemotaxis to the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
Perez HD; Elfman F; Chenoweth D; Hooper C
J Immunol; 1986 Mar; 136(5):1813-9. PubMed ID: 3753994
[TBL] [Abstract][Full Text] [Related]
10. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
[TBL] [Abstract][Full Text] [Related]
11. Alterations in chemotactic factor-induced responses of neutrophils and monocytes from chronic dialysis patients.
Lewis SL; Van Epps DE; Chenoweth DE
Clin Nephrol; 1988 Aug; 30(2):63-72. PubMed ID: 2846218
[TBL] [Abstract][Full Text] [Related]
12. Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/IL-8.
Djeu JY; Matsushima K; Oppenheim JJ; Shiotsuki K; Blanchard DK
J Immunol; 1990 Mar; 144(6):2205-10. PubMed ID: 2155963
[TBL] [Abstract][Full Text] [Related]
13. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.
Colotta F; Orlando S; Fadlon EJ; Sozzani S; Matteucci C; Mantovani A
J Exp Med; 1995 Jun; 181(6):2181-6. PubMed ID: 7760005
[TBL] [Abstract][Full Text] [Related]
14. Polymorphonuclear leukocytes cap a derivative of wheat germ agglutinin upon stimulation with formyl peptide and C5a but not leukotriene B4.
Kurrasch R; Elfman F; Perez HD
J Immunol; 1989 Sep; 143(6):1969-73. PubMed ID: 2550548
[TBL] [Abstract][Full Text] [Related]
15. A derivative of wheat germ agglutinin specifically inhibits formyl-peptide-induced polymorphonuclear leukocyte chemotaxis by blocking re-expression (or recycling) of receptors.
Perez HD; Elfman F; Lobo E; Sklar L; Chenoweth D; Hooper C
J Immunol; 1986 Mar; 136(5):1803-12. PubMed ID: 3753993
[TBL] [Abstract][Full Text] [Related]
16. Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells.
Charo IF; Yuen C; Perez HD; Goldstein IM
J Immunol; 1986 May; 136(9):3412-9. PubMed ID: 3514759
[TBL] [Abstract][Full Text] [Related]
17. Independent regulation of human neutrophil chemotactic receptors after activation.
Bender JG; Van Epps DE; Chenoweth DE
J Immunol; 1987 Nov; 139(9):3028-33. PubMed ID: 2822801
[TBL] [Abstract][Full Text] [Related]
18. Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.
Martin TR; Raugi G; Merritt TL; Henderson WR
J Clin Invest; 1987 Oct; 80(4):1114-24. PubMed ID: 2821074
[TBL] [Abstract][Full Text] [Related]
19. Receptor-mediated O2- release by alveolar macrophages and peripheral blood monocytes from smokers and nonsmokers. Priming and triggering effects of monomeric IgG, concanavalin A, N-formyl-methionyl-leucyl-phenylalanine, phorbol myristate acetate, and cytochalasin D.
Nakashima H; Ando M; Sugimoto M; Suga M; Soda K; Araki S
Am Rev Respir Dis; 1987 Aug; 136(2):310-5. PubMed ID: 3039878
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of indomethacin against chemotactic deactivation of human neutrophils induced by formylated peptide.
Perianin A; Gaudry M; Marquetty C; Giroud JP; Hakim J
Biochem Pharmacol; 1988 May; 37(9):1693-8. PubMed ID: 2837237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
